Skip to content

A study to compare the strength of dexmedetomidine and lignocaine in protecting old people from suffering loss in intelligence after undergoing surgery.

Prospective randomised controlled trial comparing the effects of intraoperative dexmedetomidine and lignocaine administration over the incidence of Post Operative Cognitive Decline in the elderly - POCDDL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/08/015358
Enrollment
60
Registered
2018-08-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Elderly patients in the age group of 60-80 undergoing any open abdominal surgery irrespective of the type of surgery.

Interventions

Intervention1: Dexmedetomidine: AN alpha 2 receptor agonist, administered as a bolus dose of 0.5 micrograms per kg body weight ten minutes prior to induction and maintenance infusion of 0.5 micrograms

Sponsors

Dr Mahendran T Kurup
Lead Sponsor
Dr Puneet Khanna
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age from 60-80 years. 2 Males or Females. 3 ASA grade I and II. 4 Minimum educational level till fifth standard. 5 Undergoing any open abdominal surgery of two hours or more.

Exclusion criteria

Exclusion criteria: 1 Refusal to consent for being a part of the study. 2 Any known allergy to the intervention drugs. 3 Any history of psychiatric or neurologic disorders or previous neurosurgeries 4 Any uncontrolled systemic disease causing an adverse effect on the cognitive function of the patient. 5 Intra-operative profound hypotension or any complication warranting stopping of the intervention agents.

Design outcomes

Primary

MeasureTime frame
The incidence of POCD in both the drug intervention groups. POCD being defined as a fall of more than or equal to 20% in the post-operative neuropsychological test scores as compared to the pre-operative scores. Timepoint: Post-Operative day 3

Secondary

MeasureTime frame
Changes in the serum levels of IL-1,IL-6,TNF-alpha & S-100 beta postoperative as compared to preoperative values.Timepoint: post-operative day 3

Countries

India

Contacts

Public ContactDR PUNEET KHANNA

All India Institute Of Medical Sciences,New Delhi

k.punit@yahoo.com9873106516

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026